Takeover rumours send Biogen’s stock soaring
August 3, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Biogen, MSD, rumours, takeover
Rumours have begun to circulate that companies including MSD and Allergan are plotting a takeover bid for Biogen, after a …
Celgene’s Otezla approved for NHS use
August 3, 2016Research and Development, Sales and Marketing Celgene, NHS, NICE, apremilast
NICE has published draft guidance recommending the use of Celgene’s Otezla (apremilast) for use on the NHS for treatment of …
Teva completes $40 billion acquisition of Actavis Generics
August 3, 2016Research and Development, Sales and Marketing Actavis, Allergan, Teva, acqusition, generics
Teva has announced that it has completed its acquisition of Actavis Generics, a subsidiary of Allergan, in a transaction valued …
MSD scores EU approval for Keytruda in lung cancer
August 3, 2016Research and Development, Sales and Marketing EU, MSD, Merck, approval, keytruda, lung cancer
MSD, called Merck in the US and Canada, has announced that the European Commission has approved Keytruda (pembrolizumab) for patients …
Breakthrough therapy designation for Novartis in advanced breast cancer treatment
August 3, 2016Research and Development, Sales and Marketing Breakthrough Therapy Designation, FDA, LEE011, Novartis, ribociclib
Novartis has announced that the US Food and Drug Administration (FDA) has granted a breakthrough therapy designation to LEE011 (ribociclib) …
Shire Q2 results outpace forecasts with 56% revenue growth
August 2, 2016Research and Development, Sales and Marketing Baxalta, Shire, financial report
Shire has announced its fiscal results for Q2 2016, reporting a strong quarter with a 56% growth in total revenues …
Revenue rises at Pfizer as Ibrance and Xeljanz beat sales expectations
August 2, 2016Research and Development, Sales and Marketing 2016, Pfizer, Prevnar, Q2, Xeljanz, ibrance, results
Pfizer has published its Q2 results, which show revenues rising 11% with new drugs helping to drive the growth and …
Landmark UK ruling as judge rules PrEP can be funded on NHS
August 2, 2016Manufacturing and Production, Research and Development, Sales and Marketing Judge, NHS, PrEP, UK, available, ruling
A London high court judge has ruled in favour of a challenge brought by the National Aids Trust to allow …
Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Applied Microbiology
August 2, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories
Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection …
Evaluation of Eisai’s advanced thyroid cancer treatment blocked until 2018 in England
August 2, 2016Manufacturing and Production, Sales and Marketing CDF, Eisai, Lenvima, NHS, NICE, lenvatinib, thyroid cancer
Following negotiations between the NHS, NICE and Japanese pharmaceutical company Eisai, differentiated thyroid cancer (RAI-R DTC) drug lenvima (levatinib) has …
Success for Biogen, Ionis as spinal muscular atrophy drug performs in Phase III
August 2, 2016Manufacturing and Production, Research and Development Biogen, Ionis, phase III, spinal muscular atrophy
Biogen and Ionis Pharmaceuticals have announced that their spinal muscular atrophy treatment, nusinersen, met its primary endpoint at an interim …
Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics
August 2, 2016Manufacturing and Production, Research and Development Pfizer, acquisition, bamboo therapeutics, gene therapy
Pfizer has announced that it has acquired gene therapy biotech Bamboo Therapeutics for an initial $150 million, with potential milestone …
Phase III success for Takeda in lymphoma drug
August 1, 2016Manufacturing and Production, Research and Development Adcetris, Seattle Genetics, Takeda, lymphoma
Takeda Oncology and Seattle Generic have announced new Phase III data for trial drug, Adcetris (brentuximab vedotin), in patients with …
FDA approves Shire’s haemophilia A treatment system
August 1, 2016Manufacturing and Production, Research and Development FDA, Shire, adynovate, baxject, haemophilia
Shire has announced that the Food and Drug Administration (FDA) has approved the baxject III reconstitution system for adynovate [antihemophilic …
The impact of Brexit on the pharmaceutical industry: some preliminary considerations
August 1, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new …
Sartorius doubles production capacity in UK with new facility
August 1, 2016Manufacturing and Production, Sales and Marketing Princess Anne, Sartorius, UK, expansion
Pharmaceutical and laboratory equipment provider Sartorius has expanded operations at its Stonehouse site in Gloucestershire with a new plant, doubling …
European Commission approves Zepatier for chronic hepatitis C infection
August 1, 2016Research and Development, Sales and Marketing
MSD, known as Merck in the US and Canada, has announced that the European Commission has approved Zepatier (elbasvir/grazoprevir) with …
Surprise for Seres as shares sent tumbling by Phase II failure
August 1, 2016Research and Development, Sales and Marketing FDA, clostrodium difficile, seres therapeutics
Seres Therapeutics has presented interim results from an ongoing Phase II trial which has sent company stock spiralling downward, as …
EMA accepts MMA for rheumatoid arthritis treatment Sarilumab
August 1, 2016Research and Development, Sales and Marketing EMA, MAA, Regeneron, Sanofi, sarilumab
Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (MAA) for …
GSK and Alphabet to create bioelectronics medicines in £540 million partnership
August 1, 2016Research and Development, Sales and Marketing Alphabet, GSK, Verily, bioelectronic medicine, galvani, google
GlaxoSmithKline and Verily Life Sciences, a division of Google’s parent company Alphabet, have announced a £540 million partnership that will …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
